| Year |
Citation |
Score |
| 2022 |
Sacks FM, Andraski AB. Dietary fat and carbohydrate affect the metabolism of protein-based high-density lipoprotein subspecies. Current Opinion in Lipidology. 33: 1-15. PMID 34907968 DOI: 10.1097/MOL.0000000000000809 |
0.334 |
|
| 2021 |
Furtado JD, Ruotolo G, Nicholls SJ, Dullea R, Carvajal-Gonzalez S, Sacks FM. Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA121317181. PMID 34937388 DOI: 10.1161/ATVBAHA.121.317181 |
0.321 |
|
| 2021 |
Belanger MJ, Wee CC, Mukamal KJ, Miller ER, Sacks FM, Appel LJ, Shmerling RH, Choi HK, Juraschek SP. Effects of dietary macronutrients on serum urate: results from the OmniHeart trial. The American Journal of Clinical Nutrition. PMID 33668058 DOI: 10.1093/ajcn/nqaa424 |
0.305 |
|
| 2020 |
Sacks FM, Liang L, Furtado JD, Cai T, Davidson WS, He Z, McClelland RL, Rimm EB, Jensen MK. Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120314609. PMID 32907368 DOI: 10.1161/Atvbaha.120.314609 |
0.42 |
|
| 2020 |
Hu JR, Wu Y, Sacks FM, Appel LJ, Miller Iii ER, Young JH, Juraschek SP. Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial. Bmj Open Diabetes Research & Care. 8. PMID 32868311 DOI: 10.1136/Bmjdrc-2020-001457 |
0.311 |
|
| 2020 |
Li X, Zhou T, Ma H, Heianza Y, Champagne CM, Williamson DA, Bray GA, Sacks FM, Qi L. Genetic variation of lean body mass, changes of appetite, and weight loss in response to diet interventions: the POUNDS Lost trial. Diabetes, Obesity & Metabolism. PMID 32734691 DOI: 10.1111/Dom.14155 |
0.333 |
|
| 2020 |
Li X, Sun D, Zhou T, Ma H, Heianza Y, Liang Z, Bray GA, Sacks FM, Qi L. Changes of Branched-Chain Amino Acids and Ectopic Fat in Response to Weight-loss Diets: the POUNDS Lost Trial. The Journal of Clinical Endocrinology and Metabolism. PMID 32561903 DOI: 10.1210/Clinem/Dgaa377 |
0.319 |
|
| 2020 |
Heianza Y, Zhou T, Chen Y, Huang T, Willett WC, Hu FB, Bray GA, Sacks FM, Qi L. Starch Digestion-Related Amylase Genetic Variants, Diet, and Changes in Adiposity: Analyses in Prospective Cohort Studies and a Randomized Dietary Intervention. Diabetes. PMID 32493715 DOI: 10.2337/Db19-1257 |
0.39 |
|
| 2020 |
Juraschek SP, Kovell LC, Appel LJ, Miller ER, Sacks FM, Christenson RH, Rebuck H, Chang AR, Mukamal KJ. Associations Between Dietary Patterns and Subclinical Cardiac Injury. Annals of Internal Medicine. PMID 32423348 DOI: 10.7326/M20-0336 |
0.402 |
|
| 2020 |
Chen Y, Zhou T, Sun D, Li X, Ma H, Liang Z, Heianza Y, Pei X, Bray GA, Sacks FM, Qi L. Distinct genetic subtypes of adiposity and glycemic changes in response to weight-loss diet intervention: the POUNDS Lost trial. European Journal of Nutrition. PMID 32274554 DOI: 10.1007/S00394-020-02244-X |
0.335 |
|
| 2020 |
Drouin-Chartier JP, Chen S, Li Y, Schwab AL, Stampfer MJ, Sacks FM, Rosner B, Willett WC, Hu FB, Bhupathiraju SN. Egg consumption and risk of cardiovascular disease: three large prospective US cohort studies, systematic review, and updated meta-analysis. Bmj (Clinical Research Ed.). 368: m513. PMID 32132002 DOI: 10.1136/Bmj.M513 |
0.326 |
|
| 2020 |
Heianza Y, Zhou T, DiDonato JA, Sun Q, Rexrode KM, Hu FB, Bray G, Sacks FM, Manson JE, Qi L. Abstract P205: Long-term Changes in Microbiota-dependent Metabolite Trimethylamine N-oxide and Risks of Hypertension and Coronary Heart Disease, and Their Modulation by Diet: The Nurses' Health Study and the POUNDS Lost Trial Circulation. 141. DOI: 10.1161/Circ.141.Suppl_1.P205 |
0.418 |
|
| 2020 |
Juraschek SP, Kovell LC, Appel LJ, Miller ER, Sacks FM, Christenson RH, Rebuck H, Chang AR, Mukamal KJ. Abstract 51: Effects of Dietary Patterns on Subclinical Cardiac Damage: Results From the DASH Trial Circulation. 141. DOI: 10.1161/Circ.141.Suppl_1.51 |
0.405 |
|
| 2020 |
Heianza Y, Zhou T, DiDonato JA, Bray GA, Sacks FM, Qi L. Abstract 47: Changes in Gut-microbial Metabolite L-carnitine and Improvements in Atherogenic Lipoprotein Metabolism in Overweight and Obese Individuals: The POUNDS Lost Trial Circulation. 141. DOI: 10.1161/Circ.141.Suppl_1.47 |
0.418 |
|
| 2019 |
Sun D, Zhou T, Li X, Heianza Y, Liang Z, Bray GA, Sacks FM, Qi L. Genetic Susceptibility, Dietary Protein Intake, and Changes of Blood Pressure: The POUNDS Lost Trial. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA11913. PMID 31656094 DOI: 10.1161/Hypertensionaha.119.13510 |
0.363 |
|
| 2019 |
Lian Z, Perrard XD, Peng X, Raya JL, Hernandez AA, Johnson CG, Lagor WR, Pownall HJ, Hoogeveen RC, Simon SI, Sacks FM, Ballantyne CM, Wu H. Replacing Saturated Fat With Unsaturated Fat in Western Diet Reduces Foamy Monocytes and Atherosclerosis in Male Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA119313078. PMID 31619061 DOI: 10.1161/Atvbaha.119.313078 |
0.402 |
|
| 2019 |
Rodriguez A, Trigatti BL, Mineo C, Knaack D, Wilkins JT, Sahoo D, Asztalos BF, Mora S, Cuchel M, Pownall HJ, Rosales C, Bernatchez P, Ribeiro Martins da Silva A, Getz GS, Barber JL, ... ... Sacks FM, et al. Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA119313340. PMID 31597448 DOI: 10.1161/Atvbaha.119.313340 |
0.361 |
|
| 2019 |
Andraski AB, Singh SA, Lee LH, Higashi H, Smith N, Zhang B, Aikawa M, Sacks FM. Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA119312889. PMID 31554421 DOI: 10.1161/Atvbaha.119.312889 |
0.423 |
|
| 2019 |
Ardisson Korat AV, Li Y, Sacks F, Rosner B, Willett WC, Hu FB, Sun Q. Dairy fat intake and risk of type 2 diabetes in 3 cohorts of US men and women. The American Journal of Clinical Nutrition. PMID 31414137 DOI: 10.1093/Ajcn/Nqz176 |
0.343 |
|
| 2019 |
Zhou T, Heianza Y, Chen Y, Li X, Sun D, DiDonato JA, Pei X, LeBoff MS, Bray GA, Sacks FM, Qi L. Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial. Diabetes Care. 42: 1365-1371. PMID 31332027 DOI: 10.2337/Dc19-0134 |
0.31 |
|
| 2019 |
Bray GA, Krauss RM, Sacks FM, Qi L. Lessons Learned from the POUNDS Lost Study: Genetic, Metabolic, and Behavioral Factors Affecting Changes in Body Weight, Body Composition, and Cardiometabolic Risk. Current Obesity Reports. PMID 31214942 DOI: 10.1007/S13679-019-00353-1 |
0.328 |
|
| 2019 |
Miketinas DC, Bray GA, Beyl RA, Ryan DH, Sacks FM, Champagne CM. Fiber Intake Predicts Weight Loss and Dietary Adherence in Adults Consuming Calorie-Restricted Diets: The POUNDS Lost (Preventing Overweight Using Novel Dietary Strategies) Study. The Journal of Nutrition. PMID 31174214 DOI: 10.1093/Jn/Nxz117 |
0.326 |
|
| 2019 |
Cahill LE, Sacks FM, Rimm EB, Jensen MK. Cholesterol efflux capacity, HDL cholesterol, and risk of coronary heart disease: a nested case-control study in men Journal of Lipid Research. 60: 1457-1464. PMID 31142574 DOI: 10.1194/Jlr.P093823 |
0.42 |
|
| 2019 |
Morton AM, Furtado JD, Mendivil CO, Sacks FM. Dietary unsaturated fat increases HDL metabolic pathways involving apoE favorable to reverse cholesterol transport Jci Insight. 4. PMID 30944249 DOI: 10.1172/Jci.Insight.124620 |
0.456 |
|
| 2019 |
Hjorth MF, Bray GA, Zohar Y, Urban L, Miketinas DC, Williamson DA, Ryan DH, Rood J, Champagne CM, Sacks FM, Astrup A. Pretreatment Fasting Glucose and Insulin as Determinants of Weight Loss on Diets Varying in Macronutrients and Dietary Fibers-The POUNDS LOST Study. Nutrients. 11. PMID 30861997 DOI: 10.3390/Nu11030586 |
0.376 |
|
| 2019 |
Armitage J, Baigent C, Barnes E, Betteridge DJ, Blackwell L, Blazing M, Bowman L, Braunwald E, Byington R, Cannon C, Clearfield M, Colhoun H, Collins R, Dahlöf B, Davies K, ... ... Sacks F, et al. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials The Lancet. 393: 407-415. PMID 30712900 DOI: 10.1016/S0140-6736(18)31942-1 |
0.348 |
|
| 2019 |
Li X, Sun D, Zhou T, Bray G, Sacks F, Qi L. 1573-P: Branched-Chain Amino Acids, Dietary Protein, and Improvement in Hepatic Fat and Abdominal Fat Distribution in Weight-Loss Diet Intervention: The POUNDS Lost Trial Diabetes. 68. DOI: 10.2337/Db19-1573-P |
0.398 |
|
| 2019 |
Zhang B, Guglielmo B, Furtado JD, Sacks FM. Abstract P200: Unsaturated Fat Replacing Carbohydrate or Protein Affects Protein-Based HDL Subspecies of Different Functionality Circulation. 139. DOI: 10.1161/Circ.139.Suppl_1.P200 |
0.311 |
|
| 2019 |
Zhou T, Heianza Y, Chen Y, Sun D, Pei X, Bray G, Sacks F, Qi L. Abstract P028: Gut Microbiota-Related Metabolites and Long-Term Bone Health in Response to Weight-Loss Diets: The POUNDS Lost Trial Circulation. 139. DOI: 10.1161/Circ.139.Suppl_1.P028 |
0.3 |
|
| 2019 |
Li X, Sun D, Zhou T, Heianza Y, Bray G, Sacks F, Qi L. Abstract MP60: Changes in Gut Microbiota Metabolite TMAO Are Related to Changes in Hepatic and Visceral Fat in Weight-loss Diet Interventions: the POUNDS Lost Trial Circulation. 139. DOI: 10.1161/Circ.139.Suppl_1.Mp60 |
0.342 |
|
| 2019 |
Andraski AB, Singh SA, Lee L, Higashi H, Smith N, Aikawa M, Sacks FM. Abstract MP41: A Diet High in Carbohydrate and Low in Fat Alters the HDL Proteome and Metabolism of 9 HDL Proteins in Humans Circulation. 139. DOI: 10.1161/Circ.139.Suppl_1.Mp41 |
0.397 |
|
| 2018 |
Furtado JD, Yamamoto R, Melchior JT, Andraski AB, Gamez-Guerrero M, Mulcahy P, He Z, Cai T, Davidson WS, Sacks FM. Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies. Arteriosclerosis, Thrombosis, and Vascular Biology. 38: 2827-2842. PMID 30571168 DOI: 10.1161/Atvbaha.118.311607 |
0.389 |
|
| 2018 |
Zhou T, Sun D, Heianza Y, Li X, Champagne CM, LeBoff MS, Shang X, Pei X, Bray GA, Sacks FM, Qi L. Genetically determined vitamin D levels and change in bone density during a weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial. The American Journal of Clinical Nutrition. 108: 1129-1134. PMID 30475961 DOI: 10.1093/Ajcn/Nqy197 |
0.323 |
|
| 2018 |
Cuchel M, Rohatgi A, Sacks FM, Guyton JR. JCL roundtable: High-density lipoprotein function and reverse cholesterol transport. Journal of Clinical Lipidology. 12: 1086-1094. PMID 30314802 DOI: 10.1016/J.Jacl.2018.09.005 |
0.417 |
|
| 2018 |
Qi L, Bray GA, Sacks FM. Low-Fat vs Low-Carbohydrate Diets and Weight Loss. Jama. 320: 202-203. PMID 29998330 DOI: 10.1001/Jama.2018.6244 |
0.362 |
|
| 2018 |
Sun D, Heianza Y, Li X, Shang X, Smith SR, Bray GA, Sacks FM, Qi L. Genetic, epigenetic, and transcriptional variations at NFATC2IP locus with weight loss in response to diet interventions: The POUNDS Lost Trial. Diabetes, Obesity & Metabolism. PMID 29693310 DOI: 10.1111/Dom.13333 |
0.365 |
|
| 2018 |
Goni L, Sun D, Heianza Y, Wang T, Huang T, Martínez JA, Shang X, Bray GA, Smith SR, Sacks FM, Qi L. A circadian rhythm-related MTNR1B genetic variant modulates the effect of weight-loss diets on changes in adiposity and body composition: the POUNDS Lost trial. European Journal of Nutrition. PMID 29516223 DOI: 10.1007/S00394-018-1660-Y |
0.345 |
|
| 2018 |
Morton AM, Koch M, Mendivil CO, Furtado JD, Tjønneland A, Overvad K, Wang L, Jensen MK, Sacks FM. Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk. Jci Insight. 3. PMID 29467335 DOI: 10.1172/Jci.Insight.98045 |
0.367 |
|
| 2018 |
Sacks FM, Jensen MK. From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 38: 487-499. PMID 29371248 DOI: 10.1161/Atvbaha.117.307025 |
0.373 |
|
| 2018 |
Yamamoto R, Sacks FM, Hu FB, Rosner B, Furtado JD, Aroner SA, Ferrannini E, Baldi S, Kozakova M, Balkau B, Natali A, Jensen MK. High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals. Atherosclerosis. 269: 92-99. PMID 29351856 DOI: 10.1016/J.Atherosclerosis.2017.12.029 |
0.391 |
|
| 2018 |
Heianza Y, Sun D, Smith SR, Bray GA, Sacks FM, Qi L. Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial. Diabetes Care. PMID 29305401 DOI: 10.2337/Dc17-2108 |
0.349 |
|
| 2018 |
Lian Z, Perrard XD, Peng X, Joe LR, Hernandez AA, Johnson CG, Lagor W, Hoogeveen R, Simon SI, Sacks F, Ballantyne C, Wu H. Abstract 598: Monounsaturated Fat Reduces Foamy Monocyte Formation and Atherosclerosis Development in Ldlr -/- Mice Compared to Western High Saturated Fat Diet Arteriosclerosis, Thrombosis, and Vascular Biology. 38. DOI: 10.1161/Atvb.38.Suppl_1.598 |
0.359 |
|
| 2018 |
Morton A, Mendivil C, Furtado J, Sacks FM. Abstract 557: The Effect of Dietary Fat and Carbohydrate on the Metabolism of HDL Subspecies Containing ApoE in Humans Arteriosclerosis, Thrombosis, and Vascular Biology. 38. DOI: 10.1161/Atvb.38.Suppl_1.557 |
0.385 |
|
| 2018 |
Andraski AB, Singh SA, Lee L, Higashi H, Smith N, Aikawa M, Sacks FM. Abstract 166: Effects of Dietary Unsaturated Fat and Carbohydrate on the HDL Proteome and Metabolism of 9 HDL Proteins Across 6 HDL Size Fractions in Humans Arteriosclerosis, Thrombosis, and Vascular Biology. 38. DOI: 10.1161/Atvb.38.Suppl_1.166 |
0.393 |
|
| 2017 |
Jensen MK, Aroner SA, Mukamal KJ, Furtado JD, Post WS, Tsai MY, Tjønneland A, Polak JF, Rimm EB, Overvad K, McClelland RL, Sacks FM. HDL Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts. Circulation. PMID 29162611 DOI: 10.1161/Circulationaha.117.031276 |
0.424 |
|
| 2017 |
Goni L, Sun D, Heianza Y, Wang T, Wang T, Cuervo M, Martinez JA, Shang X, Bray GA, Sacks FM, Qi L. Macronutrient-specific effect of the MTNR1B genotype on lipid levels in response to 2-year weight-loss diets. Journal of Lipid Research. PMID 29089366 DOI: 10.1194/Jlr.P078634 |
0.432 |
|
| 2017 |
Juraschek SP, Woodward M, Sacks FM, Carey VJ, Miller ER, Appel LJ. Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet. Hypertension (Dallas, Tex. : 1979). PMID 28993451 DOI: 10.1161/Hypertensionaha.117.10017 |
0.372 |
|
| 2017 |
Han L, Ma W, Sun D, Heianza Y, Wang T, Zheng Y, Huang T, Duan D, Bray JGA, Champagne CM, Sacks FM, Qi L. Genetic variation of habitual coffee consumption and glycemic changes in response to weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. The American Journal of Clinical Nutrition. PMID 28931532 DOI: 10.3945/Ajcn.117.156232 |
0.388 |
|
| 2017 |
Rosenson RS, Brewer HB, Barter PJ, Björkegren JLM, Chapman MJ, Gaudet D, Kim DS, Niesor E, Rye KA, Sacks FM, Tardif JC, Hegele RA. HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology. Nature Reviews. Cardiology. PMID 28795686 DOI: 10.1038/Nrcardio.2017.115 |
0.39 |
|
| 2017 |
Heianza Y, Sun D, Wang T, Huang T, Bray GA, Sacks FM, Qi L. Starch Digestion Related Amylase Genetic Variant Affects 2-Year Changes in Adiposity in Response to Weight-Loss Diets: the POUNDS Lost Trial. Diabetes. PMID 28659346 DOI: 10.2337/Db16-1482 |
0.351 |
|
| 2017 |
Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG, Stone NJ, Van Horn LV. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation. PMID 28620111 DOI: 10.1161/Cir.0000000000000510 |
0.44 |
|
| 2017 |
Kakarmath SS, Zack RM, Leyna GH, Fahimi S, Liu E, Fawzi WW, Lukmanji Z, Killewo J, Sacks F, Danaei G. Dietary determinants of serum total cholesterol among middle-aged and older adults: a population-based cross-sectional study in Dar es Salaam, Tanzania. Bmj Open. 7. PMID 28588111 DOI: 10.1136/Bmjopen-2016-015028 |
0.368 |
|
| 2017 |
Aroner SA, Yang M, Li J, Furtado JD, Sacks FM, Tjønneland A, Overvad K, Cai T, Jensen MK. Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk. American Journal of Epidemiology. PMID 28520887 DOI: 10.1093/Aje/Kwx143 |
0.348 |
|
| 2017 |
Melchior JT, Street SE, Andraski AB, Furtado JD, Sacks FM, Shute RL, Greve EI, Swertfeger DK, Li H, Shah AS, Lu LJ, Davidson WS. Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1. Journal of Lipid Research. PMID 28476857 DOI: 10.1194/Jlr.M075382 |
0.323 |
|
| 2017 |
Koch M, Furtado JD, Jiang GZ, Gray BE, Cai T, Sacks F, Tjønneland A, Overvad K, Jensen MK. Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III. Journal of Lipid Research. PMID 28365588 DOI: 10.1194/Jlr.P073288 |
0.392 |
|
| 2017 |
Bray GA, Ryan DH, Johnson W, Champagne CM, Johnson CM, Rood J, Williamson DA, Sacks FM. Markers of dietary protein intake are associated with successful weight loss in the POUNDS Lost trial. Clinical Obesity. PMID 28340516 DOI: 10.1111/Cob.12188 |
0.349 |
|
| 2016 |
Juraschek SP, Miller ER, Selvin E, Carey VJ, Appel LJ, Christenson RH, Sacks FM. Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial. Bmj Open Diabetes Research & Care. 4: e000276. PMID 27933186 DOI: 10.1136/Bmjdrc-2016-000276 |
0.362 |
|
| 2016 |
Morton AM, Furtado JD, Lee J, Amerine W, Davidson MH, Sacks FM. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia. Journal of Clinical Lipidology. 10: 1442-1451.e4. PMID 27919362 DOI: 10.1016/J.Jacl.2016.09.005 |
0.425 |
|
| 2016 |
Ma W, Huang T, Heianza Y, Wang T, Sun D, Tong J, Williamson DA, Bray GA, Sacks FM, Qi L. Genetic variations of circulating adiponectin levels modulate changes in appetite in response to weight-loss diets. The Journal of Clinical Endocrinology and Metabolism. jc20162909. PMID 27841942 DOI: 10.1210/Jc.2016-2909 |
0.318 |
|
| 2016 |
Heianza Y, Ma W, Huang T, Wang T, Zheng Y, Smith SR, Bray GA, Sacks FM, Qi L. Macronutrient Intake-Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial. Diabetes Care. PMID 27581055 DOI: 10.2337/Dc16-1111 |
0.37 |
|
| 2016 |
Ma W, Huang T, Wang M, Zheng Y, Wang T, Heianza Y, Sun D, Smith SR, Bray GA, Sacks FM, Qi L. Two-year changes in circulating adiponectin, ectopic fat distribution, and body composition in response to weight-loss diets: The POUNDS lost trial. International Journal of Obesity (2005). PMID 27460602 DOI: 10.1038/Ijo.2016.128 |
0.348 |
|
| 2016 |
Vadiveloo M, Sacks FM, Champagne CM, Bray GA, Mattei J. Greater Healthful Dietary Variety Is Associated with Greater 2-Year Changes in Weight and Adiposity in the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial. The Journal of Nutrition. PMID 27358422 DOI: 10.3945/Jn.115.224683 |
0.33 |
|
| 2016 |
Huang T, Ley SH, Zheng Y, Wang T, Bray GA, Sacks FM, Qi L. Genetic susceptibility to diabetes and long-term improvement of insulin resistance and β cell function during weight loss: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. The American Journal of Clinical Nutrition. PMID 27281308 DOI: 10.3945/Ajcn.115.121186 |
0.334 |
|
| 2016 |
Wang T, Huang T, Zheng Y, Rood J, Bray GA, Sacks FM, Qi L. Genetic variation of fasting glucose and changes in glycemia in response to 2-year weight-loss diet intervention: the POUNDS LOST trial. International Journal of Obesity (2005). PMID 27113490 DOI: 10.1038/Ijo.2016.41 |
0.327 |
|
| 2016 |
Ma W, Huang T, Zheng Y, Wang M, Bray GA, Sacks FM, Qi L. Weight-loss diets, adiponectin, and changes in cardiometabolic risk in the 2-year POUNDS Lost Trial. The Journal of Clinical Endocrinology and Metabolism. jc20161207. PMID 27055193 DOI: 10.1210/Jc.2016-1207 |
0.367 |
|
| 2016 |
Singh SA, Andraski AB, Pieper B, Goh W, Mendivil CO, Sacks FM, Aikawa M. Multiple apolipoprotein kinetics measured in human HDL by high resolution/accurate mass parallel reaction monitoring. Journal of Lipid Research. PMID 26862155 DOI: 10.1194/Jlr.D061432 |
0.317 |
|
| 2016 |
Zheng Y, Ceglarek U, Huang T, Li L, Rood J, Ryan DH, Bray GA, Sacks FM, Schwarzfuchs D, Thiery J, Shai I, Qi L. Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials. The American Journal of Clinical Nutrition. PMID 26791187 DOI: 10.3945/Ajcn.115.117689 |
0.346 |
|
| 2015 |
Brown WV, Sacks FM, Sniderman AD. JCL roundtable: Apolipoproteins as causative elements in vascular disease. Journal of Clinical Lipidology. 9: 733-40. PMID 26687693 DOI: 10.1016/J.Jacl.2015.10.003 |
0.414 |
|
| 2015 |
Juraschek SP, McAdams-Demarco M, Gelber AC, Sacks FM, Appel LJ, White K, Miller ER. Effects of Lowering Glycemic Index of Dietary Carbohydrate on Plasma Uric Acid: The OmniCarb Randomized Clinical Trial. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26636424 DOI: 10.1002/Art.39527 |
0.324 |
|
| 2015 |
Mendivil CO, Furtado J, Morton AM, Wang L, Sacks FM. Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26543096 DOI: 10.1161/Atvbaha.115.306138 |
0.389 |
|
| 2015 |
Qi Q, Zheng Y, Huang T, Rood J, Bray GA, Sacks FM, Qi L. Vitamin D metabolism-related genetic variants, dietary protein intake and improvement of insulin resistance in a 2 year weight-loss trial: POUNDS Lost. Diabetologia. PMID 26416604 DOI: 10.1007/S00125-015-3750-1 |
0.307 |
|
| 2015 |
Wyler von Ballmoos MC, Haring B, Sacks FM. The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis. Journal of Clinical Lipidology. 9: 498-510. PMID 26228667 DOI: 10.1016/J.Jacl.2015.05.002 |
0.373 |
|
| 2015 |
Lin X, Qi Q, Zheng Y, Huang T, Lathrop M, Zelenika D, Bray GA, Sacks FM, Liang L, Qi L. Neuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trial. The American Journal of Clinical Nutrition. 102: 514-9. PMID 26156739 DOI: 10.3945/Ajcn.115.107276 |
0.361 |
|
| 2015 |
Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA, Aggarwal NT. Mediterranean-dietary approach to systolic hypertension diet intervention for neurodegenerative delay diet slows cognitive decline with aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26086182 DOI: 10.1016/J.Jalz.2015.04.011 |
0.339 |
|
| 2015 |
Desai NK, Ooi EM, Mitchell PD, Furtado J, Sacks FM. Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans. Atherosclerosis. 241: 326-333. PMID 26071654 DOI: 10.1016/J.Atherosclerosis.2015.05.013 |
0.312 |
|
| 2015 |
Xu M, Ng SS, Bray GA, Ryan DH, Sacks FM, Ning G, Qi L. Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial. The Journal of Nutrition. 145: 1289-94. PMID 25926410 DOI: 10.3945/Jn.115.212514 |
0.444 |
|
| 2015 |
Sacks FM, Appel LJ, Carey VJ. Low vs high glycemic index diet--reply. Jama. 313: 1372-3. PMID 25849187 DOI: 10.1001/Jama.2015.2081 |
0.368 |
|
| 2015 |
Mega JL, Stitziel NO, Smith JG, Chasman DI, Caulfield MJ, Devlin JJ, Nordio F, Hyde CL, Cannon CP, Sacks FM, Poulter NR, Sever PS, Ridker PM, Braunwald E, Melander O, et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet (London, England). 385: 2264-71. PMID 25748612 DOI: 10.1016/S0140-6736(14)61730-X |
0.339 |
|
| 2015 |
Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25681666 DOI: 10.1016/J.Jalz.2014.11.009 |
0.358 |
|
| 2015 |
Sacks FM. The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia. Current Opinion in Lipidology. 26: 56-63. PMID 25551803 DOI: 10.1097/Mol.0000000000000146 |
0.3 |
|
| 2015 |
Qi Q, Durst R, Schwarzfuchs D, Leitersdorf E, Shpitzen S, Li Y, Wu H, Champagne CM, Hu FB, Stampfer MJ, Bray GA, Sacks FM, Shai I, Qi L. CETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials. Journal of Lipid Research. 56: 713-21. PMID 25548261 DOI: 10.1194/Jlr.P055715 |
0.445 |
|
| 2015 |
Huang T, Huang J, Qi Q, Li Y, Bray GA, Rood J, Sacks FM, Qi L. PCSK7 genotype modifies effect of a weight-loss diet on 2-year changes of insulin resistance: the POUNDS LOST trial. Diabetes Care. 38: 439-44. PMID 25504030 DOI: 10.2337/Dc14-0473 |
0.322 |
|
| 2014 |
Wang L, Sacks FM, Furtado JD, Ricks M, Courville AB, Sumner AE. Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins. Nutrition & Metabolism. 11: 56. PMID 25553059 DOI: 10.1186/1743-7075-11-56 |
0.356 |
|
| 2014 |
Sacks FM, Carey VJ, Anderson CA, Miller ER, Copeland T, Charleston J, Harshfield BJ, Laranjo N, McCarron P, Swain J, White K, Yee K, Appel LJ. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial. Jama. 312: 2531-41. PMID 25514303 DOI: 10.1001/Jama.2014.16658 |
0.361 |
|
| 2014 |
Haring B, von Ballmoos MC, Appel LJ, Sacks FM. Healthy dietary interventions and lipoprotein (a) plasma levels: results from the Omni Heart Trial. Plos One. 9: e114859. PMID 25506933 DOI: 10.1371/Journal.Pone.0114859 |
0.358 |
|
| 2014 |
Talayero B, Wang L, Furtado J, Carey VJ, Bray GA, Sacks FM. Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease. Journal of Lipid Research. 55: 2167-77. PMID 24966274 DOI: 10.1194/Jlr.M042333 |
0.384 |
|
| 2014 |
Sacks FM, Brewer HB. Petar Alaupovic: The father of lipoprotein classification based on apolipoprotein composition. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 1111-3. PMID 24945028 DOI: 10.1161/Atvbaha.114.303500 |
0.355 |
|
| 2014 |
Postmus I, Johnson PC, Trompet S, de Craen AJ, Slagboom PE, Devlin JJ, Shiffman D, Sacks FM, Kearney PM, Stott DJ, Buckley BM, Sattar N, Ford I, Westendorp RG, Jukema JW. In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study. Atherosclerosis. 235: 58-64. PMID 24816038 DOI: 10.1016/J.Atherosclerosis.2014.04.009 |
0.342 |
|
| 2014 |
Ha V, Sievenpiper JL, de Souza RJ, Jayalath VH, Mirrahimi A, Agarwal A, Chiavaroli L, Mejia SB, Sacks FM, Di Buono M, Bernstein AM, Leiter LA, Kris-Etherton PM, Vuksan V, Bazinet RP, et al. Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: a systematic review and meta-analysis of randomized controlled trials. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 186: E252-62. PMID 24710915 DOI: 10.1503/Cmaj.131727 |
0.368 |
|
| 2014 |
Miyazaki T, Chiuve S, Sacks FM, Ridker PM, Libby P, Aikawa M. Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial. Plos One. 9: e94073. PMID 24705587 DOI: 10.1371/Journal.Pone.0094073 |
0.38 |
|
| 2014 |
Huang T, Qi Q, Li Y, Hu FB, Bray GA, Sacks FM, Williamson DA, Qi L. FTO genotype, dietary protein, and change in appetite: the Preventing Overweight Using Novel Dietary Strategies trial. The American Journal of Clinical Nutrition. 99: 1126-30. PMID 24622803 DOI: 10.3945/Ajcn.113.082164 |
0.31 |
|
| 2014 |
Causland FRM, Sacks FM, Forman JP. Marital status, dipping and nocturnal blood pressure: Results from the Dietary Approaches to Stop Hypertension trial Journal of Hypertension. 32: 756-761. PMID 24509120 DOI: 10.1097/Hjh.0000000000000107 |
0.359 |
|
| 2014 |
Sacks FM, Hermans MP, Fioretto P, Valensi P, Davis T, Horton E, Wanner C, Al-Rubeaan K, Aronson R, Barzon I, Bishop L, Bonora E, Bunnag P, Chuang LM, Deerochanawong C, et al. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation. 129: 999-1008. PMID 24352521 DOI: 10.1161/Circulationaha.113.002529 |
0.338 |
|
| 2014 |
O'Donoghue ML, Morrow DA, Tsimikas S, Sloan S, Ren AF, Hoffman EB, Desai NR, Solomon SD, Domanski M, Arai K, Chiuve SE, Cannon CP, Sacks FM, Sabatine MS. Lipoprotein(a) for risk assessment in patients with established coronary artery disease Journal of the American College of Cardiology. 63: 520-527. PMID 24161323 DOI: 10.1016/J.Jacc.2013.09.042 |
0.374 |
|
| 2013 |
Qi Q, Xu M, Wu H, Liang L, Champagne CM, Bray GA, Sacks FM, Qi L. IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: the POUNDS LOST trial. Diabetes Care. 36: 3442-7. PMID 24009303 DOI: 10.2337/Dc13-0018 |
0.383 |
|
| 2013 |
Nicklas JM, Sacks FM, Smith SR, LeBoff MS, Rood JC, Bray GA, Ridker PM. Effect of dietary composition of weight loss diets on high-sensitivity c-reactive protein: the Randomized POUNDS LOST trial. Obesity (Silver Spring, Md.). 21: 681-9. PMID 23712970 DOI: 10.1002/Oby.20072 |
0.363 |
|
| 2013 |
Mendivil CO, Rimm EB, Furtado J, Sacks FM. Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease Journal of the American Heart Association. 2. PMID 23672999 DOI: 10.1161/Jaha.113.000130 |
0.42 |
|
| 2013 |
Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H, Sacks FM, Rimm EB, Wang M, Siscovick DS. Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Annals of Internal Medicine. 158: 515-25. PMID 23546563 DOI: 10.7326/0003-4819-158-7-201304020-00003 |
0.333 |
|
| 2013 |
Fretts AM, Mozaffarian D, Siscovick DS, Heckbert SR, McKnight B, King IB, Rimm EB, Psaty BM, Sacks FM, Song X, Spiegelman D, Lemaitre RN. Associations of plasma phospholipid and dietary alpha linolenic acid with incident atrial fibrillation in older adults: the Cardiovascular Health Study. Journal of the American Heart Association. 2: e003814. PMID 23525429 DOI: 10.1161/Jaha.112.003814 |
0.329 |
|
| 2013 |
Xu M, Qi Q, Liang J, Bray GA, Hu FB, Sacks FM, Qi L. Genetic determinant for amino acid metabolites and changes in body weight and insulin resistance in response to weight-loss diets: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation. 127: 1283-9. PMID 23446828 DOI: 10.1161/Circulationaha.112.000586 |
0.304 |
|
| 2013 |
Gadgil MD, Appel LJ, Yeung E, Anderson CA, Sacks FM, Miller ER. The effects of carbohydrate, unsaturated fat, and protein intake on measures of insulin sensitivity: results from the OmniHeart trial. Diabetes Care. 36: 1132-7. PMID 23223345 DOI: 10.2337/Dc12-0869 |
0.356 |
|
| 2013 |
Zhang X, Qi Q, Zhang C, Hu F, Sacks F, Qi L. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST trial. Diabetes 2012;61:3005–3011 Diabetes. 62: 662-662. DOI: 10.2337/Db13-Er02A |
0.339 |
|
| 2013 |
Berglund L, Sacks F, Brunzell JD. Risk factors for cardiovascular disease: renewed interest in triglycerides Clinical Lipidology. 8: 1-4. DOI: 10.2217/Clp.12.81 |
0.408 |
|
| 2012 |
Jensen MK, Rimm EB, Furtado JD, Sacks FM. Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease. Journal of the American Heart Association. 1. PMID 23130121 DOI: 10.1161/Jaha.111.000232 |
0.408 |
|
| 2012 |
Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 126: 2880-9. PMID 23124030 DOI: 10.1161/Cir.0B013E318279Acbf |
0.336 |
|
| 2012 |
Anton SD, LeBlanc E, Allen HR, Karabetian C, Sacks F, Bray G, Williamson DA. Use of a computerized tracking system to monitor and provide feedback on dietary goals for calorie-restricted diets: the POUNDS LOST study. Journal of Diabetes Science and Technology. 6: 1216-25. PMID 23063049 DOI: 10.1177/193229681200600527 |
0.305 |
|
| 2012 |
Mattei J, Qi Q, Hu FB, Sacks FM, Qi L. TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention. The American Journal of Clinical Nutrition. 96: 1129-36. PMID 23034957 DOI: 10.3945/Ajcn.112.038125 |
0.346 |
|
| 2012 |
Anton SD, Gallagher J, Carey VJ, Laranjo N, Cheng J, Champagne CM, Ryan DH, McManus K, Loria CM, Bray GA, Sacks FM, Williamson DA. Diet type and changes in food cravings following weight loss: findings from the POUNDS LOST Trial. Eating and Weight Disorders : Ewd. 17: e101-8. PMID 23010779 DOI: 10.1007/Bf03325333 |
0.375 |
|
| 2012 |
Zhang X, Qi Q, Liang J, Hu FB, Sacks FM, Qi L. Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial. Hypertension (Dallas, Tex. : 1979). 60: 1169-75. PMID 22966009 DOI: 10.1161/Hypertensionaha.112.197855 |
0.404 |
|
| 2012 |
Zhang X, Qi Q, Bray GA, Hu FB, Sacks FM, Qi L. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial. The American Journal of Clinical Nutrition. 96: 917-22. PMID 22914552 DOI: 10.3945/Ajcn.112.040907 |
0.367 |
|
| 2012 |
Zhang X, Qi Q, Zhang C, Smith SR, Hu FB, Sacks FM, Bray GA, Qi L. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Diabetes. 61: 3005-11. PMID 22891219 DOI: 10.2337/Db11-1799 |
0.37 |
|
| 2012 |
Shiffman D, Trompet S, Louie JZ, Rowland CM, Catanese JJ, Iakoubova OA, Kirchgessner TG, Westendorp RG, de Craen AJ, Slagboom PE, Buckley BM, Stott DJ, Sattar N, Devlin JJ, Packard CJ, ... ... Sacks FM, et al. Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapy. Plos One. 7: e38240. PMID 22666496 DOI: 10.1371/Journal.Pone.0038240 |
0.341 |
|
| 2012 |
de Jonge L, Bray GA, Smith SR, Ryan DH, de Souza RJ, Loria CM, Champagne CM, Williamson DA, Sacks FM. Effect of diet composition and weight loss on resting energy expenditure in the POUNDS LOST study. Obesity (Silver Spring, Md.). 20: 2384-9. PMID 22627912 DOI: 10.1038/Oby.2012.127 |
0.368 |
|
| 2012 |
Mahajan N, Ference BA, Arora N, Madhavan R, Bhattacharya P, Sudhakar R, Sagar A, Wang Y, Sacks F, Afonso L. Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction. The American Journal of Cardiology. 109: 1694-9. PMID 22465317 DOI: 10.1016/J.Amjcard.2012.02.010 |
0.432 |
|
| 2012 |
Furtado JD, Wedel MK, Sacks FM. Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins Journal of Lipid Research. 53: 784-791. PMID 22301884 DOI: 10.1194/Jlr.P021717 |
0.396 |
|
| 2012 |
Wu JH, Lemaitre RN, King IB, Song X, Sacks FM, Rimm EB, Heckbert SR, Siscovick DS, Mozaffarian D. Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation. 125: 1084-93. PMID 22282329 DOI: 10.1161/Circulationaha.111.062653 |
0.31 |
|
| 2012 |
De Souza RJ, Bray GA, Carey VJ, Hall KD, LeBoff MS, Loria CM, Laranjo NM, Sacks FM, Smith SR. Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: Results from the POUNDS LOST trial American Journal of Clinical Nutrition. 95: 614-625. PMID 22258266 DOI: 10.3945/Ajcn.111.026328 |
0.375 |
|
| 2012 |
Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, Bhala N, Holland L, Peto R, Keech A, Collins R, Simes J, Baigent C, De Lemos J, Braunwald E, Blazing M, ... ... Sacks F, et al. Lack of effect of lowering LDL cholesterol on cancer: Meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy Plos One. 7. DOI: 10.1371/Journal.Pone.0029849 |
0.349 |
|
| 2012 |
Nicklas J, Sacks F, Smith S, LeBoff M, Rood J, Bray G, Ridker P. OA02.01. Effect of macronutrient composition of weight loss diets on reduction of the inflammatory marker hsCRP Bmc Complementary and Alternative Medicine. 12. DOI: 10.1186/1472-6882-12-S1-O5 |
0.381 |
|
| 2011 |
Mendivil CO, Rimm EB, Furtado J, Chiuve SE, Sacks FM. Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease Circulation. 124: 2065-2072. PMID 21986282 DOI: 10.1161/Circulationaha.111.056986 |
0.428 |
|
| 2011 |
Trompet S, Craen AJd, Postmus I, Ford I, Sattar N, Caslake M, Stott DJ, Buckley BM, Sacks FM, Devlin JJ, Slagboom PE, Westendorp RG, Jukema JW. Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses Bmc Medical Genetics. 12: 131-131. PMID 21977987 DOI: 10.1186/1471-2350-12-131 |
0.321 |
|
| 2011 |
Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Current Cardiology Reports. 13: 544-52. PMID 21968696 DOI: 10.1007/S11886-011-0220-3 |
0.429 |
|
| 2011 |
Qi Q, Bray GA, Smith SR, Hu FB, Sacks FM, Qi L. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation. 124: 563-71. PMID 21747052 DOI: 10.1161/Circulationaha.111.025767 |
0.306 |
|
| 2011 |
Braunwald E, Sacks FM, Pfeffer MA, Ridker PM. HMG CoA reduction in patients with average cholesterol concentrations. Clinical Chemistry. 57: 1072-3. PMID 21519035 DOI: 10.1373/Clinchem.2011.164038 |
0.406 |
|
| 2011 |
Sacks FM, Zheng C, Cohn JS. Complexities of plasma apolipoprotein C-III metabolism. Journal of Lipid Research. 52: 1067-70. PMID 21421846 DOI: 10.1194/Jlr.E015701 |
0.356 |
|
| 2011 |
Hermans MP, Sacks FM, Ahn SA, Rousseau MF. Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence. Cardiovascular Diabetology. 10: 20. PMID 21356116 DOI: 10.1186/1475-2840-10-20 |
0.36 |
|
| 2011 |
Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC, Vafiadis DK, Van Horn LV. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation. 123: 1138-43. PMID 21233236 DOI: 10.1161/Cir.0B013E31820D0793 |
0.316 |
|
| 2011 |
Millán Núñez-Cortés J, Montoya JP, Salas XP, Hernández Mijares A, Carey VJ, Hermans MP, Sacks FM, Fruchart JC. [The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: an analysis of residual risk attributable to lipid profile in acute coronary syndrome]. Endocrinología Y NutricióN : ÓRgano De La Sociedad EspañOla De Endocrinología Y NutricióN. 58: 38-47. PMID 21208833 DOI: 10.1016/J.Endonu.2010.10.004 |
0.34 |
|
| 2010 |
Furtado JD, Campos H, Sumner AE, Appel LJ, Carey VJ, Sacks FM. Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial. The American Journal of Clinical Nutrition. 92: 714-22. PMID 20826623 DOI: 10.3945/Ajcn.2009.28532 |
0.392 |
|
| 2010 |
Carey VJ, Bishop L, Laranjo N, Harshfield BJ, Kwiat C, Sacks FM. Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control. The American Journal of Cardiology. 106: 757-63. PMID 20816113 DOI: 10.1016/J.Amjcard.2010.05.002 |
0.418 |
|
| 2010 |
Sacks FM, Campos H. Dietary therapy in hypertension. The New England Journal of Medicine. 362: 2102-12. PMID 20519681 DOI: 10.1056/Nejmct0911013 |
0.368 |
|
| 2010 |
Fruchart JC, Sacks FM, Hermans MP. Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i). Current Medical Research and Opinion. 26: 1793-1797. PMID 20482323 DOI: 10.1185/03007995.2010.489341 |
0.422 |
|
| 2010 |
Shiffman D, Sabatine MS, Louie JZ, Kirchgessner TG, Iakoubova OA, Campos H, Devlin JJ, Sacks FM. Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial. The American Journal of Cardiology. 105: 1300-5. PMID 20403483 DOI: 10.1016/J.Amjcard.2009.12.049 |
0.303 |
|
| 2010 |
Zheng C, Khoo C, Furtado J, Sacks FM. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype Circulation. 121: 1722-1734. PMID 20368524 DOI: 10.1161/Circulationaha.109.875807 |
0.391 |
|
| 2010 |
Williamson DA, Anton SD, Han H, Champagne CM, Allen R, Leblanc E, Ryan DH, Rood J, McManus K, Laranjo N, Carey VJ, Loria CM, Bray GA, Sacks FM. Early behavioral adherence predicts short and long-term weight loss in the POUNDS LOST study. Journal of Behavioral Medicine. 33: 305-14. PMID 20195742 DOI: 10.1007/S10865-010-9253-0 |
0.329 |
|
| 2010 |
Mendivil CO, Zheng C, Furtado J, Lel J, Sacks FM. Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 239-245. PMID 19910636 DOI: 10.1161/Atvbaha.109.197830 |
0.381 |
|
| 2010 |
Williamson DA, Anton SD, Han H, Champagne CM, Allen R, LeBlanc E, Ryan DH, McManus K, Laranjo N, Carey VJ, Loria CM, Bray GA, Sacks FM. Adherence is a multi-dimensional construct in the POUNDS LOST trial. Journal of Behavioral Medicine. 33: 35-46. PMID 19856202 DOI: 10.1007/S10865-009-9230-7 |
0.357 |
|
| 2009 |
Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, Sacks F, Steffen LM, Wylie-Rosett J. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 120: 1011-20. PMID 19704096 DOI: 10.1161/Circulationaha.109.192627 |
0.333 |
|
| 2009 |
Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. The New England Journal of Medicine. 360: 859-73. PMID 19246357 DOI: 10.1056/Nejmoa0804748 |
0.35 |
|
| 2009 |
Beasley JM, Ange BA, Anderson CA, Miller ER, Erlinger TP, Holbrook JT, Sacks FM, Appel LJ. Associations between macronutrient intake and self-reported appetite and fasting levels of appetite hormones: results from the Optimal Macronutrient Intake Trial to Prevent Heart Disease. American Journal of Epidemiology. 169: 893-900. PMID 19224977 DOI: 10.1093/Aje/Kwn415 |
0.395 |
|
| 2009 |
Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB, Sacks F. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 119: 902-7. PMID 19171857 DOI: 10.1161/Circulationaha.108.191627 |
0.351 |
|
| 2009 |
Jacobs DR, Gross MD, Steffen L, Steffes MW, Yu X, Svetkey LP, Appel LJ, Vollmer WM, Bray GA, Moore T, Conlin PR, Sacks F. The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 53: 638-46. PMID 19167797 DOI: 10.1053/J.Ajkd.2008.10.048 |
0.362 |
|
| 2009 |
Sacks FM, Rudel LL, Conner A, Akeefe H, Kostner G, Baki T, Rothblat G, de la Llera-Moya M, Asztalos B, Perlman T, Zheng C, Alaupovic P, Maltais JA, Brewer HB. Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo. Journal of Lipid Research. 50: 894-907. PMID 19144994 DOI: 10.1194/Jlr.M800622-Jlr200 |
0.379 |
|
| 2009 |
Mendivil C, Rimm E, Furtado J, Chiuve S, Sacks F. Abstract: 1472 APOC-III CONTAINING LIPOPROTEINS AND RISK OF CORONARY HEART DISEASE Atherosclerosis Supplements. 10. DOI: 10.1016/S1567-5688(09)70438-6 |
0.418 |
|
| 2008 |
Sacks FM. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate. The American Journal of Cardiology. 102: 34L-40L. PMID 19084088 DOI: 10.1016/J.Amjcard.2008.09.073 |
0.309 |
|
| 2008 |
Sacks FM. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction. The American Journal of Cardiology. 102: 1L-3L. PMID 19084082 DOI: 10.1016/J.Amjcard.2008.09.066 |
0.373 |
|
| 2008 |
Fruchart JC, Sacks FM, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, et al. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. Diabetes & Vascular Disease Research. 5: 319-35. PMID 18958843 DOI: 10.3132/Dvdr.2008.046 |
0.407 |
|
| 2008 |
Zheng C, Khoo C, Furtado J, Ikewaki K, Sacks FM. Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III American Journal of Clinical Nutrition. 88: 272-281. PMID 18689361 DOI: 10.1093/Ajcn/88.2.272 |
0.414 |
|
| 2008 |
Kawakami A, Osaka M, Tani M, Azuma H, Sacks FM, Shimokado K, Yoshida M. Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction Circulation. 118: 731-742. PMID 18663085 DOI: 10.1161/Circulationaha.108.784785 |
0.318 |
|
| 2008 |
de Souza RJ, Swain JF, Appel LJ, Sacks FM. Alternatives for macronutrient intake and chronic disease: a comparison of the OmniHeart diets with popular diets and with dietary recommendations. The American Journal of Clinical Nutrition. 88: 1-11. PMID 18614716 DOI: 10.1093/Ajcn/88.1.1 |
0.399 |
|
| 2008 |
Furtado JD, Campos H, Appel LJ, Miller ER, Laranjo N, Carey VJ, Sacks FM. Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial. The American Journal of Clinical Nutrition. 87: 1623-30. PMID 18541549 DOI: 10.1093/Ajcn/87.6.1623 |
0.398 |
|
| 2008 |
Iakoubova O, Shepherd J, Sacks F. Association of the 719Arg variant of KIF6 with both increased risk of coronary events and with greater response to statin therapy. Journal of the American College of Cardiology. 51: 2195-2196. PMID 18510970 DOI: 10.1016/J.Jacc.2008.02.061 |
0.325 |
|
| 2008 |
Swain JF, McCarron PB, Hamilton EF, Sacks FM, Appel LJ. Characteristics of the diet patterns tested in the optimal macronutrient intake trial to prevent heart disease (OmniHeart): options for a heart-healthy diet. Journal of the American Dietetic Association. 108: 257-65. PMID 18237574 DOI: 10.1016/J.Jada.2007.10.040 |
0.355 |
|
| 2008 |
Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA, Arellano AR, Shiffman D, Sabatine MS, Campos H, Packard CJ, Pfeffer MA, White TJ, Braunwald E, Shepherd J, Devlin JJ, ... Sacks FM, et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. Journal of the American College of Cardiology. 51: 435-43. PMID 18222353 DOI: 10.1016/J.Jacc.2007.05.057 |
0.345 |
|
| 2008 |
Sabatine MS, Ploughman L, Simonsen KL, Iakoubova OA, Kirchgessner TG, Ranade K, Tsuchihashi Z, Zerba KE, Long DU, Tong CH, Packard CJ, Pfeffer MA, Devlin JJ, Shepherd J, Campos H, ... Sacks FM, et al. Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 562-567. PMID 18174457 DOI: 10.1161/Atvbaha.107.156653 |
0.328 |
|
| 2008 |
Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation. 117: 163-168. PMID 18172029 DOI: 10.1161/Circulationaha.107.727545 |
0.355 |
|
| 2008 |
Fruchart J, Hermans M, Sacks F, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche J, Marx N, Plutzky J, Reiner Z, et al. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. American Journal of Cardiology. 102: 1. DOI: 10.1016/J.Amjcard.2008.10.002 |
0.413 |
|
| 2007 |
Karanja N, Lancaster KJ, Vollmer WM, Lin PH, Most MM, Ard JD, Swain JF, Sacks FM, Obarzanek E. Acceptability of sodium-reduced research diets, including the Dietary Approaches To Stop Hypertension diet, among adults with prehypertension and stage 1 hypertension. Journal of the American Dietetic Association. 107: 1530-8. PMID 17761230 DOI: 10.1016/J.Jada.2007.06.013 |
0.339 |
|
| 2007 |
Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Jama. 298: 309-316. PMID 17635891 DOI: 10.1001/Jama.298.3.309 |
0.394 |
|
| 2007 |
Zheng C, Khoo C, Ikewaki K, Sacks FM. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions. Journal of Lipid Research. 48: 1190-1203. PMID 17314277 DOI: 10.1194/Jlr.P600011-Jlr200 |
0.346 |
|
| 2007 |
Sacks FM, Rudel L, Asztalos BF, Zheng CY, Conner A, Akeefe H, Perlman T, Maltais J, Rothblat GH, Brewer HB. Lb-Or-4 Selective Delipidation Of Hdl In Plasma Produces Pre-Beta Hdl Effective In Reverse Cholesterol Transport In Vivo In Monkeys Atherosclerosis Supplements. 8: 228. DOI: 10.1016/S1567-5688(07)71865-2 |
0.328 |
|
| 2006 |
Iakoubova OA, Tong CH, Chokkalingam AP, Rowland CM, Kirchgessner TG, Louie JZ, Ploughman LM, Sabatine MS, Campos H, Catanese JJ, Leong DU, Young BA, Lew D, Tsuchihashi Z, Luke MM, ... ... Sacks FM, et al. Asp92Asn polymorphism in the myeloid IgA Fc receptor is associated with myocardial infarction in two disparate populations: CARE and WOSCOPS. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 2763-8. PMID 17008591 DOI: 10.1161/01.Atv.0000247248.76409.8B |
0.312 |
|
| 2006 |
Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, et al. Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 2186-91. PMID 16990564 DOI: 10.1161/01.Atv.0000238352.25222.5E |
0.442 |
|
| 2006 |
Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 1689-92. PMID 16857959 DOI: 10.1161/01.Atv.0000227471.00284.Ef |
0.412 |
|
| 2006 |
Sacks FM. The apolipoprotein story. Atherosclerosis Supplements. 7: 23-27. PMID 16822722 DOI: 10.1016/J.Atherosclerosissup.2006.05.004 |
0.399 |
|
| 2006 |
Chiuve SE, McCullough ML, Sacks FM, Rimm EB. Healthy Lifestyle Factors in the Primary Prevention of Coronary Heart Disease Among Men Benefits Among Users and Nonusers of Lipid-Lowering and Antihypertensive Medications Circulation. 114: 160-167. PMID 16818808 DOI: 10.1161/Circulationaha.106.621417 |
0.376 |
|
| 2006 |
Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 114: 82-96. PMID 16785338 DOI: 10.1161/Circulationaha.106.176158 |
0.432 |
|
| 2006 |
Zheng C, Ikewaki K, Walsh BW, Sacks FM. Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat Journal of Lipid Research. 47: 1771-1779. PMID 16685082 DOI: 10.1194/Jlr.M500528-Jlr200 |
0.359 |
|
| 2006 |
Tonelli M, Sacks F, Pfeffer M, Lopez-Jimenez F, Jhangri GS, Curhan G. Effect of pravastatin on blood pressure in people with cardiovascular disease Journal of Human Hypertension. 20: 560-565. PMID 16625234 DOI: 10.1038/Sj.Jhh.1002036 |
0.326 |
|
| 2006 |
Kawakami A, Aikawa M, Libby P, Alcaide P, Luscinskas FW, Sacks FM. Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells Circulation. 113: 691-700. PMID 16461842 DOI: 10.1161/Circulationaha.105.591743 |
0.356 |
|
| 2006 |
Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension (Dallas, Tex. : 1979). 47: 296-308. PMID 16434724 DOI: 10.1161/01.Hyp.0000202568.01167.B6 |
0.38 |
|
| 2006 |
Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation. 113: 1034-44. PMID 16418439 DOI: 10.1161/Circulationaha.106.171052 |
0.419 |
|
| 2006 |
Zheng C, Murdoch SJ, Brunzell JD, Sacks FM. Lipoprotein lipase bound to apolipoprotein B lipoproteins accelerates clearance of postprandial lipoproteins in humans Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 891-896. PMID 16410459 DOI: 10.1161/01.Atv.0000203512.01007.3D |
0.389 |
|
| 2006 |
Tonelli M, Sacks F, Pfeffer M, Gao ZH, Curhan G, Investigators RE(T. Serum Phosphate: A Novel Cardiovascular Risk Factor Even in Nonrenal Patients Relation between Serum Phosphate Level and Cardiovascular Event Rate in People with Coronary Disease. Circulation 112: 2627-2633, 2005 Journal of the American Society of Nephrology. 17: 2077-2085. DOI: 10.1681/Asn.2006060608 |
0.328 |
|
| 2005 |
Carey VJ, Bishop L, Charleston J, Conlin P, Erlinger T, Laranjo N, McCarron P, Miller E, Rosner B, Swain J, Sacks FM, Appel LJ. Rationale and design of the Optimal Macro-Nutrient Intake Heart Trial to Prevent Heart Disease (OMNI-Heart). Clinical Trials (London, England). 2: 529-37. PMID 16422313 DOI: 10.1191/1740774505Cn123Oa |
0.433 |
|
| 2005 |
Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men Circulation. 112: 3375-3383. PMID 16316964 DOI: 10.1161/Circulationaha.104.532499 |
0.377 |
|
| 2005 |
Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM, Charleston J, McCarron P, Bishop LM. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. Jama. 294: 2455-64. PMID 16287956 DOI: 10.1001/Jama.294.19.2455 |
0.435 |
|
| 2005 |
Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 112: 2627-33. PMID 16246962 DOI: 10.1161/Circulationaha.105.553198 |
0.309 |
|
| 2005 |
Ranade K, Kirchgessner TG, Iakoubova OA, Devlin JJ, DelMonte T, Vishnupad P, Hui L, Tsuchihashi Z, Sacks FM, Sabatine MS, Braunwald E, White TJ, Shaw PM, Dracopoli NC. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke; a Journal of Cerebral Circulation. 36: 2346-50. PMID 16239632 DOI: 10.1161/01.Str.0000185703.88944.7D |
0.315 |
|
| 2005 |
Miller ER, Erlinger TP, Sacks FM, Svetkey LP, Charleston J, Lin PH, Appel LJ. A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: results from a randomized controlled feeding study. Atherosclerosis. 183: 175-82. PMID 16216596 DOI: 10.1016/J.Atherosclerosis.2005.04.001 |
0.316 |
|
| 2005 |
Campos H, Khoo C, Sacks FM. Diurnal and acute patterns of postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from normolipidemic humans. Atherosclerosis. 181: 345-51. PMID 16039289 DOI: 10.1016/J.Atherosclerosis.2004.12.045 |
0.34 |
|
| 2005 |
Sacks FM. Dietary Phytoestrogens to Prevent Cardiovascular Disease Early Promise Unfulfilled Circulation. 111: 385-387. PMID 15687122 DOI: 10.1161/01.Cir.0000155232.57701.4D |
0.309 |
|
| 2005 |
Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, Grooth GJd, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, et al. Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin Treatment Individual Patient Meta-Analysis of 13 677 Subjects Circulation. 111: 278-287. PMID 15655129 DOI: 10.1161/01.Cir.0000153341.46271.40 |
0.4 |
|
| 2005 |
Chiuve SE, Martin LA, Campos H, Sacks FM. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other high-density lipoproteins in surgically postmenopausal women Obstetrical and Gynecological Survey. 60: 39-41. DOI: 10.1097/01.Ogx.0000143792.82025.16 |
0.398 |
|
| 2005 |
Chiuve S, McCullough M, Sacks F, Stampfer M, Willett W, Rimm E. L8: Healthy Lifestyle Behaviors and Risk of Coronary Heart Disease among Men: Effects of Adherence and Change American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S152 |
0.304 |
|
| 2004 |
Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation. 110: 1557-63. PMID 15364796 DOI: 10.1161/01.Cir.0000143892.84582.60 |
0.302 |
|
| 2004 |
Byington RP, Sacks FM. Lessons learned from the prospective pravastatin pooling project. Current Atherosclerosis Reports. 6: 366-374. PMID 15296703 DOI: 10.1007/S11883-004-0048-Z |
0.336 |
|
| 2004 |
Svetkey LP, Simons‐Morton DG, Proschan MA, Sacks FM, Conlin PR, Harsha D, Moore TJ. Effect of the Dietary approaches to Stop Hypertension diet and reduced sodium intake on blood pressure control Journal of Clinical Hypertension. 6: 373-381. PMID 15249792 DOI: 10.1111/J.1524-6175.2004.03523.X |
0.357 |
|
| 2004 |
Bray GA, Vollmer WM, Sacks FM, Obarzanek E, Svetkey LP, Appel LJ. A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial. The American Journal of Cardiology. 94: 222-7. PMID 15246908 DOI: 10.1016/J.Amjcard.2004.03.070 |
0.382 |
|
| 2004 |
Rifai N, Ma J, Sacks FM, Ridker PM, Hernandez WJ, Stampfer MJ, Marcovina SM. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study. Clinical Chemistry. 50: 1364-71. PMID 15155542 DOI: 10.1373/Clinchem.2003.030031 |
0.368 |
|
| 2004 |
Chiuve SE, Martin LA, Campos H, Sacks FM. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women. The Journal of Clinical Endocrinology and Metabolism. 89: 2207-13. PMID 15126543 DOI: 10.1210/Jc.2003-031564 |
0.399 |
|
| 2004 |
de Grooth GJ, Zerba KE, Huang SP, Tsuchihashi Z, Kirchgessner T, Belder R, Vishnupad P, Hu B, Klerkx AH, Zwinderman AH, Jukema JW, Sacks FM, Kastelein JJ, Kuivenhoven JA. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy. Journal of the American College of Cardiology. 43: 854-7. PMID 14998629 DOI: 10.1016/J.Jacc.2003.08.056 |
0.357 |
|
| 2004 |
Sacks FM. High-intensity statin treatment for coronary heart disease. Jama. 291: 1132-1134. PMID 14996784 DOI: 10.1001/Jama.291.9.1132 |
0.365 |
|
| 2004 |
Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, Natarajan K, Sheng-Lin C, Fiedorek FT, Belder R. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Archives of Internal Medicine. 164: 40-4. PMID 14718320 DOI: 10.1001/Archinte.164.1.40 |
0.355 |
|
| 2004 |
Harsha DW, Sacks FM, Obarzanek E, Svetkey LP, Lin PH, Bray GA, Aickin M, Conlin PR, Miller ER, Appel LJ. Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial. Hypertension (Dallas, Tex. : 1979). 43: 393-8. PMID 14707154 DOI: 10.1161/01.Hyp.0000113046.83819.A2 |
0.454 |
|
| 2003 |
Seeger JD, Walker AM, Williams PL, Saperia GM, Sacks FM. A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction. American Journal of Cardiology. 92: 1447-1451. PMID 14675584 DOI: 10.1016/J.Amjcard.2003.08.057 |
0.311 |
|
| 2003 |
Lee S, Sacks FM. Effect of Pravastatin on intermediate-density and low-density lipoproteins containing apolipoprotein CIII in patients with diabetes mellitus American Journal of Cardiology. 92: 121-124. PMID 12860210 DOI: 10.1016/S0002-9149(03)00524-1 |
0.374 |
|
| 2003 |
Lee SJ, Moye LA, Campos H, Williams GH, Sacks FM. Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease. Atherosclerosis. 167: 293-302. PMID 12818412 DOI: 10.1016/S0021-9150(03)00007-8 |
0.351 |
|
| 2003 |
Akita S, Sacks FM, Svetkey LP, Conlin PR, Kimura G. Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet on the Pressure-Natriuresis Relationship Hypertension. 42: 8-13. PMID 12756219 DOI: 10.1161/01.Hyp.0000074668.08704.6E |
0.357 |
|
| 2003 |
Lee SJ, Campos H, Moye LA, Sacks FM. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 853-8. PMID 12637336 DOI: 10.1161/01.Atv.0000066131.01313.Eb |
0.368 |
|
| 2003 |
Sacks FM, Campos H. Cardiovascular endocrinology 4: Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal Journal of Clinical Endocrinology and Metabolism. 88: 4525-4532. DOI: 10.1210/Jc.2003-030636 |
0.401 |
|
| 2003 |
Hennekens CH, Sacks FM, Tonkin A, Jukema W, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, Natarajan K, Sheng-Lin C, Fiedorek FT, Belder R. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: Randomized and observational comparisons of secondary prevention trials and their meta-analysis Journal of the American College of Cardiology. 41: 526. DOI: 10.1016/S0735-1097(03)82825-5 |
0.328 |
|
| 2003 |
Lin P, Aickin M, Champagne C, Craddick S, Sacks FM, Mccarron P, Most-Windhauser MM, Rukenbrod F, Haworth L. Food group sources of nutrients in the dietary patterns of the DASH-Sodium trial Journal of the American Dietetic Association. 103: 488-496. DOI: 10.1016/S0002-8223(03)00014-2 |
0.343 |
|
| 2002 |
Sacks FM, Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. The American Journal of Medicine. 113: 13-24. PMID 12566134 DOI: 10.1016/S0002-9343(01)00987-1 |
0.476 |
|
| 2002 |
Sacks FM. Dietary fat, the Mediterranean diet, and health: reports from scientific exchanges, 1998 and 2000. Introduction. The American Journal of Medicine. 1S-4S. PMID 12566131 DOI: 10.1016/S0002-9343(01)00985-8 |
0.343 |
|
| 2002 |
Sacks FM. Low-density lipoprotein lowering therapy: an analysis of the options. Journal of the American College of Cardiology. 40: 2135-2138. PMID 12505225 DOI: 10.1016/S0735-1097(02)02609-8 |
0.39 |
|
| 2002 |
Sacks FM. Adherence to statin therapy: why aren't we doing better? The American Journal of Medicine. 113: 685-686. PMID 12505120 DOI: 10.1016/S0002-9343(02)01428-6 |
0.411 |
|
| 2002 |
Sacks FM, Alaupovic P, Moye LA. Effect of pravastatin on apolipoproteins B and C-III in very-low-density lipoproteins and low-density lipoproteins. The American Journal of Cardiology. 90: 165-7. PMID 12106851 DOI: 10.1016/S0002-9149(02)02444-X |
0.33 |
|
| 2002 |
Sacks FM. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. American Journal of Cardiology. 90: 139-143. PMID 12106843 DOI: 10.1016/S0002-9149(02)02436-0 |
0.458 |
|
| 2002 |
Sacks FM, Tonkin AM, Craven T, Pfeffer MA, Shepherd J, Keech A, Furberg CD, Braunwald E. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors. Circulation. 105: 1424-8. PMID 11914249 DOI: 10.1161/01.Cir.0000012918.84068.43 |
0.423 |
|
| 2002 |
Liu S, Schmitz C, Stampfer MJ, Sacks F, Hennekens CH, Lindpaintner K, Ridker PM. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis. 161: 469-474. PMID 11888533 DOI: 10.1016/S0021-9150(01)00673-6 |
0.349 |
|
| 2002 |
Lin Y, Smith TJ, Wypij D, Kelsey KT, Sacks FM. Association of the Blood/Air Partition Coefficient of 1,3-Butadiene with Blood Lipids and Albumin Environmental Health Perspectives. 110: 165-168. PMID 11836145 DOI: 10.1289/Ehp.02110165 |
0.329 |
|
| 2002 |
Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, Conlin PR, Svetkey LP, Erlinger TP, Moore TJ, Karanja N. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Annals of Internal Medicine. 135: 1019-28. PMID 11747380 DOI: 10.7326/0003-4819-135-12-200112180-00005 |
0.361 |
|
| 2001 |
Vollmer WM, Sacks FM, Svetkey LP. New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products. Trials. 2: 71-74. PMID 11806776 DOI: 10.1186/Cvm-2-2-071 |
0.396 |
|
| 2001 |
Sacks FM. The relative role of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in coronary artery disease: evidence from large-scale statin and fibrate trials American Journal of Cardiology. 88: 14-18. PMID 11788125 DOI: 10.1016/S0002-9149(01)02147-6 |
0.407 |
|
| 2001 |
Svetkey LP, Moore TJ, Simons-Morton DG, Appel LJ, Bray GA, Sacks FM, Ard JD, Mortensen RM, Mitchell SR, Conlin PR, Kesari M. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study Journal of Hypertension. 19: 1949-1956. PMID 11677359 DOI: 10.1097/00004872-200111000-00004 |
0.385 |
|
| 2001 |
McManus K, Antinoro L, Sacks F. A randomized controlled trial of a moderate-fat, low-energy diet compared with a low fat, low-energy diet for weight loss in overweight adults International Journal of Obesity. 25: 1503-1511. PMID 11673773 DOI: 10.1038/Sj.Ijo.0801796 |
0.379 |
|
| 2001 |
Campos H, Moye LA, Glasser SP, Stampfer MJ, Sacks FM. Low-density lipoprotein size, pravastatin treatment, and coronary events Journal of the American Medical Association. 286: 1468-1474. PMID 11572739 DOI: 10.1001/Jama.286.12.1468 |
0.403 |
|
| 2001 |
Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER, Lin P, Karanja NM, Most-Windhauser MM, Moore TJ, Swain JF, Bales CW, Proschan MA. Effects on blood lipids of a blood pressure–lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial The American Journal of Clinical Nutrition. 74: 80-89. PMID 11451721 DOI: 10.1093/Ajcn/74.1.80 |
0.469 |
|
| 2001 |
Tsevat J, Kuntz KM, Orav EJ, Weinstein MC, Sacks FM, Goldman L. Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels American Heart Journal. 141: 727-734. PMID 11320359 DOI: 10.1067/Mhj.2001.114805 |
0.324 |
|
| 2001 |
Sacks FM. Lipid-Lowering Therapy in Acute Coronary Syndromes Jama. 285: 1758-1760. PMID 11277832 DOI: 10.1001/Jama.285.13.1758 |
0.363 |
|
| 2001 |
Kris-Etherton P, Daniels SR, Eckel RH, Engler M, Howard BV, Krauss RM, Lichtenstein AH, Sacks F, St Jeor S, Stampfer M, Eckel RH, Grundy SM, Appel LJ, Byers T, Campos H, ... ... Sacks F, et al. Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. Circulation. 103: 1034-9. PMID 11181482 DOI: 10.1161/01.Cir.103.7.1034 |
0.335 |
|
| 2001 |
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin PH, Aickin M, Most-Windhauser MM, Moore TJ, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (dash) diet New England Journal of Medicine. 344: 3-10. PMID 11136953 DOI: 10.1056/Nejm200101043440101 |
0.394 |
|
| 2000 |
Sacks FM, Tonkin AM, Shepherd J, Braunwald E, Cobbe S, Hawkins CM, Keech A, Packard C, Simes J, Byington R, Furberg CD. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation. 102: 1893-900. PMID 11034935 DOI: 10.1161/01.Cir.102.16.1893 |
0.331 |
|
| 2000 |
Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, Pfeffer MA, Braunwald E. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial Circulation. 102: 1886-1892. PMID 11034934 DOI: 10.1161/01.Cir.102.16.1886 |
0.429 |
|
| 2000 |
Conlin PR, Chow D, Miller ER, Svetkey LP, Lin P, Harsha DW, Moore TJ, Sacks FM, Appel LJ. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. American Journal of Hypertension. 13: 949-955. PMID 10981543 DOI: 10.1016/S0895-7061(99)00284-8 |
0.38 |
|
| 2000 |
Obarzanek E, Sacks FM, Moore TJ, Vollmer WM, Bray GA, Miller ER, Lin PH, Karanja N, Windhauser MM, Swain JF, Bales C, Proschan MA. F002: The dash (dietary approaches to stop hypertension) diet lowers blood lipids American Journal of Hypertension. 13. DOI: 10.1016/S0895-7061(00)00501-X |
0.353 |
|
| 2000 |
Sacks F, Tonkin A, Shepherd J, Braunwald E, Cobbe S, Hawkins M, Keech A, Packard C, Simes J, Byington R, Furberg C. Prospective pravastatin pooling project: Relative risk reduction by baseline HDL and TG concentrations Atherosclerosis. 151: 41. DOI: 10.1016/S0021-9150(00)80183-5 |
0.316 |
|
| 1999 |
Moore TJ, Vollmer WM, Appel LJ, Sacks FM, Svetkey LP, Vogt TM, Conlin PR, Simons-Morton DG, Carter-Edwards L, Harsha DW. Effect of dietary patterns on ambulatory blood pressure: Results from the dietary approaches to Stop Hypertension (DASH) Trial Hypertension. 34: 472-477. PMID 10489396 DOI: 10.1161/01.Hyp.34.3.472 |
0.386 |
|
| 1999 |
Svetkey LP, Sacks FM, Obarzanek E, Vollmer WM, Appel LJ, Lin PH, Karanja NM, Harsha DW, Bray GA, Aickin M, Proschan MA, Windhauser MM, Swain JF, McCarron PB, Rhodes DG, et al. The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-Sodium): Rationale and design Journal of the American Dietetic Association. 99. PMID 10450301 DOI: 10.1016/S0002-8223(99)00423-X |
0.383 |
|
| 1999 |
Vogt TM, Appel LJ, Obarzanek E, Moore TJ, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Cutler JA, Windhauser MM, Lin PH, Karanja NM. Dietary Approaches to Stop Hypertension: Rationale, design, and methods Journal of the American Dietetic Association. 99. PMID 10450289 DOI: 10.1016/S0002-8223(99)00411-3 |
0.352 |
|
| 1999 |
Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 100: 230-5. PMID 10411845 DOI: 10.1161/01.Cir.100.3.230 |
0.335 |
|
| 1999 |
Sacks FM, Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A dietary approach to prevent hypertension: A review of the dietary approaches to stop hypertension (DASH) study Clinical Cardiology. 22. PMID 10410299 DOI: 10.1002/Clc.4960221503 |
0.378 |
|
| 1999 |
Flaker GC, Warnica JW, Sacks FM, Moyé LA, Davis BR, Rouleau JL, Webel RR, Pfeffer MA, Braunwald E. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. Journal of the American College of Cardiology. 34: 106-12. PMID 10399998 DOI: 10.1016/S0735-1097(99)00145-X |
0.354 |
|
| 1999 |
Hu FB, Stampfer MJ, Rimm EB, Manson JE, Ascherio A, Colditz GA, Rosner BA, Spiegelman D, Speizer FE, Sacks FM, Hennekens CH, Willett WC. A prospective study of egg consumption and risk of cardiovascular disease in men and women Journal of the American Medical Association. 281: 1387-1394. PMID 10217054 DOI: 10.1001/Jama.281.15.1387 |
0.341 |
|
| 1999 |
Sacks FM, Ridker PM. Lipid lowering and beyond: Results from the CARE study on lipoproteins and inflammation Herz. 24: 51-56. PMID 10093013 DOI: 10.1007/Bf03043818 |
0.316 |
|
| 1999 |
Walsh BW, Spiegelman D, Morrissey M, Sacks FM. Relationship between Serum Estradiol Levels and the Increases in High-Density Lipoprotein Levels in Postmenopausal Women Treated with Oral Estradiol The Journal of Clinical Endocrinology and Metabolism. 84: 985-989. PMID 10084583 DOI: 10.1210/Jcem.84.3.5571 |
0.309 |
|
| 1999 |
Pfeffer MA, Sacks FM, Moyé LA, East C, Goldman S, Nash DT, Rouleau JR, Rouleau JL, Sussex BA, Theroux P, Vanden Belt RJ, Braunwald E. Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events. Journal of the American College of Cardiology. 33: 125-30. PMID 9935018 DOI: 10.1016/S0735-1097(98)00522-1 |
0.37 |
|
| 1999 |
Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis The American Journal of Clinical Nutrition. 69: 30-42. PMID 9925120 DOI: 10.1093/Ajcn/69.1.30 |
0.364 |
|
| 1999 |
Plehn JF, Davis BR, Sacks FM, Rouleau JL, Pfeffer MA, Bernstein V, Cuddy TE, Moyé LA, Piller LB, Rutherford J, Simpson LM, Braunwald E. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation. 99: 216-23. PMID 9892586 DOI: 10.1161/01.Cir.99.2.216 |
0.314 |
|
| 1999 |
Lewis SJ, Sacks F, Braunwald E. Cholesterol Lowering in Older Patients Annals of Internal Medicine. 131: 155-156. DOI: 10.7326/0003-4819-131-2-199907200-00021 |
0.334 |
|
| 1998 |
Sacks FM. Why cholesterol as a central theme in coronary artery disease American Journal of Cardiology. 82: 14-17. PMID 9860368 DOI: 10.1016/S0002-9149(98)00717-6 |
0.382 |
|
| 1998 |
Goldberg RB, Mellies MJ, Sacks FM, Moyé LA, Howard BV, Howard WJ, Davis BR, Cole TG, Pfeffer MA, Braunwald E. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: Subgroup analyses in the Cholesterol And Recurrent Events (CARE) trial Circulation. 98: 2513-2519. PMID 9843456 DOI: 10.1161/01.Cir.98.23.2513 |
0.368 |
|
| 1998 |
Lewis SJ, Moye LA, Sacks FM, Johnstone DE, Timmis G, Mitchell J, Limacher M, Kell S, Glasser SP, Grant J, Davis BR, Pfeffer MA, Braunwald E. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the cholesterol and recurrent events (CARE) trial Annals of Internal Medicine. 129: 681-689. PMID 9841599 DOI: 10.7326/0003-4819-129-9-199811010-00002 |
0.377 |
|
| 1998 |
Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Circulation. 98: 839-844. PMID 9738637 DOI: 10.1161/01.Cir.98.9.839 |
0.357 |
|
| 1998 |
Lewis SJ, Sacks FM, Mitchell JS, East C, Glasser S, Kell S, Letterer R, Limacher M, Moye LA, Rouleau JL, Pfeffer MA, Braunwald E. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. Journal of the American College of Cardiology. 32: 140-6. PMID 9669262 DOI: 10.1016/S0735-1097(98)00202-2 |
0.341 |
|
| 1998 |
Sacks FM, Moyé LA, Davis BR, Cole TG, Rouleau JL, Nash DT, Pfeffer MA, Braunwald E. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation. 97: 1446-52. PMID 9576424 DOI: 10.1161/01.Cir.97.15.1446 |
0.372 |
|
| 1998 |
Arnold J, Davis B, Nash D, Insul W, Lewis S, Kohn R, Glasser S, Belew K, Kimmet B, Sacks F. Lipid levels, adherence to medication, baseline characteristics in the cholesterol and recurrent events (CARE) study Journal of the American College of Cardiology. 31: 89. DOI: 10.1016/S0735-1097(98)81031-0 |
0.326 |
|
| 1998 |
Papademetriou V, Nash D, Narayan P, Davis B, Simpson L, Marais G, Rouleau J, Sacks F. Influence of calcium channel blocker therapy on cardiovascular outcomes in the Cholesterol and Recurrent Events (CARE) trial Journal of the American College of Cardiology. 31: 407. DOI: 10.1016/S0735-1097(98)80117-4 |
0.304 |
|
| 1998 |
Warnica JW, Flaker GC, Moyo L, Sacks F. Pravastatin prevents ischemic events after angioplasty in myocardial infarction patients with an average cholesterol Journal of the American College of Cardiology. 31: 404. DOI: 10.1016/S0735-1097(98)80105-8 |
0.312 |
|
| 1997 |
Campos H, Walsh BW, Judge H, Sacks FM. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism. 82: 3955-3963. PMID 9398695 DOI: 10.1210/Jcem.82.12.4437 |
0.367 |
|
| 1997 |
Moyé LA, Davis BR, Sacks F, Cole T, Brown L, Hawkins CM. Decision rules for predicting future lipid values in screening for a cholesterol reduction clinical trial. Controlled Clinical Trials. 17: 536-46. PMID 8974212 DOI: 10.1016/S0197-2456(96)00085-2 |
0.381 |
|
| 1997 |
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure Journal of Materials Science: Materials in Medicine. 8: 1117-1124. DOI: 10.1056/Nejm199704173361601 |
0.357 |
|
| 1997 |
Goldberg R, Moyé L, Howard B, Howard W, Mellies M, Sacks F, Braunwald E. 1.P.146 Cholesterol reduction with pravastatin in CARE patients is beneficial irrespective of fasting glucose levels Atherosclerosis. 134: 47. DOI: 10.1016/S0021-9150(97)88324-4 |
0.306 |
|
| 1996 |
Silva ERDOe, Seidman CE, Tian JJ, Hudgins LC, Sacks FM, Breslow JL. Effects of shrimp consumption on plasma lipoproteins The American Journal of Clinical Nutrition. 64: 712-717. PMID 8901790 DOI: 10.1093/Ajcn/64.5.712 |
0.449 |
|
| 1996 |
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. The New England Journal of Medicine. 335: 1001-9. PMID 8801446 DOI: 10.1056/Nejm199610033351401 |
0.402 |
|
| 1996 |
Wilt TJ, Davis BR, Meyers DG, Rouleau JL, Sacks FM. Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: baseline results from the Cholesterol and Recurrent Events (CARE) Study. Angiology. 47: 533-41. PMID 8678327 DOI: 10.1177/000331979604700601 |
0.381 |
|
| 1996 |
O'Hanesian MA, Rosner B, Bishop LM, Sacks FM. Effects of inherent responsiveness to diet and day-to-day diet variation on plasma lipoprotein concentrations The American Journal of Clinical Nutrition. 64: 53-59. PMID 8669414 DOI: 10.1093/Ajcn/64.1.53 |
0.429 |
|
| 1996 |
Ascherio A, Cho E, Walsh K, Sacks FM, Willett WC, Faruqui A. Premature coronary deaths in Asians. Bmj. 312: 508-508. PMID 8597699 DOI: 10.1136/Bmj.312.7029.508 |
0.343 |
|
| 1996 |
Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction Jama. 276: 882-888. DOI: 10.1001/Jama.1996.03540110036029 |
0.399 |
|
| 1995 |
Sacks FM, Rouleau JL, Moye LA, Pfeffer MA, Warnica JW, Arnold JM, Nash DT, Brown LE, Sestier F, Rutherford J. Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels. The American Journal of Cardiology. 75: 621-3. PMID 7887392 DOI: 10.1016/S0002-9149(99)80631-6 |
0.387 |
|
| 1995 |
Michels KB, Sacks FM. Trans Fatty Acids In European Margarines The New England Journal of Medicine. 332: 541-542. PMID 7830748 DOI: 10.1056/Nejm199502233320817 |
0.338 |
|
| 1995 |
Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. Journal of the American College of Cardiology. 25: 387-94. PMID 7829792 DOI: 10.1016/0735-1097(94)00370-6 |
0.306 |
|
| 1995 |
Yamamoto ME, Applegate WB, Klag MJ, Borhani NO, Cohen JD, Kirchner KA, Lakatos E, Sacks FM, Taylor JO, Hennekens CH. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Annals of Epidemiology. 5: 96-107. PMID 7795837 DOI: 10.1016/1047-2797(94)00054-W |
0.305 |
|
| 1995 |
Whelton PK, Buring J, Borhani NO, Cohen JD, Cook N, Cutler JA, Kiley JE, Kuller LH, Satterfield S, Sacks FM, Taylor JO. The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP) Annals of Epidemiology. 5: 85-95. PMID 7795836 DOI: 10.1016/1047-2797(94)00053-V |
0.304 |
|
| 1995 |
Sacks FM, Obarzanek E, Windhauser MM, Svetkey LP, Vollmer WM, McCullough M, Karanja N, Lin PH, Steele P, Proschan MA, Evans MA, Appel LJ, Bray GA, Vogt TM, Moore TJ, et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure Annals of Epidemiology. 5: 108-118. PMID 7795829 DOI: 10.1016/1047-2797(94)00055-X |
0.392 |
|
| 1995 |
Sacks FM. Is there anything to add to our lipid risk factors for coronary heart disease American Journal of Cardiology. 75: 1263-1264. PMID 7778551 DOI: 10.1016/S0002-9149(99)80774-7 |
0.331 |
|
| 1995 |
Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC. Controlled trial of fish oil for regression of human coronary atherosclerosis Journal of the American College of Cardiology. 25: 1492-1498. PMID 7759696 DOI: 10.1016/0735-1097(95)00095-L |
0.337 |
|
| 1995 |
Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D. Mediterranean diet pyramid: a cultural model for healthy eating The American Journal of Clinical Nutrition. 61. PMID 7754995 DOI: 10.1093/Ajcn/61.6.1402S |
0.374 |
|
| 1995 |
Sacks FM, Gerhard M, Walsh BW. Sex hormones, lipoproteins, and vascular reactivity. Current Opinion in Lipidology. 6: 161-166. PMID 7648005 DOI: 10.1097/00041433-199506000-00008 |
0.342 |
|
| 1995 |
Pfeifer MA, Sacks FM, Moye LA, Brown L, Rouleau JL, Hartley LH, Rouleau J, Grimm R, Sestier F, Wickemeyer W, Cole TG, Braunwold E. Cholesterol and recurrent events: A secondary prevention trial for normolipidemic patients American Journal of Cardiology. 76. PMID 7572695 DOI: 10.1016/S0002-9149(99)80478-0 |
0.438 |
|
| 1995 |
Sacks FM, Michael Gibson C, Rosner B, Pasternak RC, Stone PH. The influence of pretreatment lew density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials The American Journal of Cardiology. 76. PMID 7572692 DOI: 10.1016/S0002-9149(99)80475-5 |
0.409 |
|
| 1994 |
Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ. Prospective Study of Plasma Fatty Acids and Risk of Prostate Cancer Journal of the National Cancer Institute. 86: 281-286. PMID 8158682 DOI: 10.1093/Jnci/86.4.281 |
0.307 |
|
| 1994 |
Sacks FM, Walsh BW. Sex hormones and lipoprotein metabolism Current Opinion in Lipidology. 5: 236-240. PMID 7952919 DOI: 10.1097/00041433-199405030-00012 |
0.344 |
|
| 1994 |
Sacks FM, Pasternak RC, Gibson CM, Rosner B, Stone PH. Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients The Lancet. 344: 1182-1186. PMID 7934538 DOI: 10.1016/S0140-6736(94)90506-1 |
0.412 |
|
| 1994 |
Sacks FM, Hebert P, Appel LJ, Borhani NO, Applegate WB, Cohen JD, Cutler JA, Kirchner KA, Kuller LH, Roth KJ, Taylor JO, Hennekens CH. Short report : the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the trials of hypertension prevention Journal of Hypertension. 12: 209-213. DOI: 10.1097/00004872-199402000-00014 |
0.372 |
|
| 1994 |
Moye LA, Davis BR, Hawkins C, Sacks F, Pfeffer MA, Cole T, Brown L, Crawford B. 62A Decision rules for predicting future lipid values in a cholesterol reduction clinical trial Controlled Clinical Trials. 15: 74. DOI: 10.1016/0197-2456(94)90123-6 |
0.309 |
|
| 1994 |
Sacks FM, McPherson R, Walsh BW. Effect of Postmenopausal Estrogen Replacement on Plasma Lp(a) Lipoprotein Concentrations Jama Internal Medicine. 154: 1106-1110. DOI: 10.1001/Archinte.1994.00420100084011 |
0.373 |
|
| 1993 |
Walsh BW, Sacks FM. Effects of Low-Dose Oral Contraceptives on Very Low-Density and Low-Density Lipoprotein Metabolism Journal of Clinical Investigation. 91: 2126-2132. PMID 8486779 DOI: 10.1172/Jci116437 |
0.317 |
|
| 1993 |
Campos H, Sacks FM, Walsh BW, Schiff I, O'Hanesian MA, Krauss RM. Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism: Clinical and Experimental. 42: 1153-8. PMID 8412768 DOI: 10.1016/0026-0495(93)90273-Q |
0.383 |
|
| 1993 |
Ridker PM, Vaughan DE, Stampfer MJ, Sacks FM, Hennekens CH. A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100. Arteriosclerosis and Thrombosis : a Journal of Vascular Biology. 13: 1587-92. PMID 8218099 DOI: 10.1161/01.Atv.13.11.1587 |
0.382 |
|
| 1992 |
Whelton PK, Appel L, Charleston J, Dalcin AT, Ewart C, Fried L, Kaidy D, Klag MJ, Kumanyika S, Steffen L, Walker WG, Oberman A, Counts K, Hataway H, Raczynski J, ... ... Sacks F, et al. The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I Jama. 267: 1213-1220. PMID 1586398 DOI: 10.1001/Jama.1992.03480090061028 |
0.313 |
|
| 1992 |
Hunter DJ, Rimm EB, Sacks FM, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. American Journal of Epidemiology. 135: 418-427. PMID 1550093 DOI: 10.1093/Oxfordjournals.Aje.A116302 |
0.346 |
|
| 1992 |
Sacks FM. Desirable serum total cholesterol with low HDL cholesterol levels. An undesirable situation in coronary heart disease. Circulation. 86: 1341-1344. PMID 1394943 DOI: 10.1161/01.Cir.86.4.1341 |
0.404 |
|
| 1991 |
Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. The New England Journal of Medicine. 325: 373-381. PMID 2062328 DOI: 10.1056/Nejm199108083250601 |
0.402 |
|
| 1991 |
Willett W, Sacks FM. Chewing the fat--how much and what kind? The New England Journal of Medicine. 324: 121-123. PMID 1984177 DOI: 10.1056/Nejm199101103240209 |
0.391 |
|
| 1991 |
Sacks FM, Willett WW. More on chewing the fat. The good fat and the good cholesterol. The New England Journal of Medicine. 325: 1740-1742. PMID 1944476 DOI: 10.1056/Nejm199112123252411 |
0.367 |
|
| 1991 |
Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. The New England Journal of Medicine. 325: 1196-1204. PMID 1922206 DOI: 10.1056/Nejm199110243251702 |
0.372 |
|
| 1991 |
London SJ, Sacks FM, Caesar J, Stampfer MJ, Siguel E, Willett WC. Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. The American Journal of Clinical Nutrition. 54: 340-345. PMID 1858698 DOI: 10.1093/Ajcn/54.2.340 |
0.303 |
|
| 1991 |
Sacks FM, Pfeffer MA, Moye' L, Brown LE, Hamm P, Cole TG, Hawkins CM, Braunwald E. Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE) The American Journal of Cardiology. 68: 1436-46. PMID 1746424 DOI: 10.1016/0002-9149(91)90276-Q |
0.423 |
|
| 1990 |
Reis GJ, Silverman DI, Boucher TM, Sipperly ME, Horowitz GL, Sacks FM, Pasternak RC. Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease American Journal of Cardiology. 66: 1171-1175. PMID 2239719 DOI: 10.1016/0002-9149(90)91093-L |
0.334 |
|
| 1990 |
Swain JF, Rouse IL, Curley CB, Sacks FM. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure The New England Journal of Medicine. 322: 147-152. PMID 2152973 DOI: 10.1056/Nejm199001183220302 |
0.396 |
|
| 1990 |
Silverman DI, Reis GJ, Sacks FM, Boucher TM, Pasternak RC. Usefulness of plasma phospholipid N-3 fatty acid levels in predicting dietary fish intake in patients with coronary artery disease American Journal of Cardiology. 66: 860-862. PMID 2145737 DOI: 10.1016/0002-9149(90)90367-A |
0.371 |
|
| 1989 |
Alderman JD, Pasternak RC, Sacks FM, Smith HS, Monrad ES, Grossman W. Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio American Journal of Cardiology. 64: 725-729. PMID 2801522 DOI: 10.1016/0002-9149(89)90754-6 |
0.406 |
|
| 1989 |
Sacks FM, Creager MA, Gallagher SJ, Loscalzo J, Dzau VJ. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension. The American Journal of Medicine. 86: 8-13. PMID 2563311 DOI: 10.1016/0002-9343(89)90121-6 |
0.366 |
|
| 1989 |
Ascherio A, Rimm EB, Giovannucci EL, Colditz G, Rosner B, Willett WC, Sacks F, Stampfer MJ. A prospective study of nutritional factors and hypertension among US men. Circulation. 86: 1475-1484. PMID 1330360 DOI: 10.1161/01.Cir.86.5.1475 |
0.331 |
|
| 1989 |
Hankinson SE, London SJ, Chute CG, Barbieri RL, Jones L, Kaplan LA, Sacks FM, Stampfer MJ. Effect of transport conditions on the stability of biochemical markers in blood. Clinical Chemistry. 35: 2313-2316. DOI: 10.1093/Clinchem/35.12.2313 |
0.312 |
|
| 1988 |
Sacks FM, Kass EH. Low blood pressure in vegetarians: effects of specific foods and nutrients. The American Journal of Clinical Nutrition. 48: 795-800. PMID 3414588 DOI: 10.1093/Ajcn/48.3.795 |
0.361 |
|
| 1988 |
Kushi LH, Samonds KW, Lacey JM, Brown PT, Bergan JG, Sacks FM. The association of dietary fat with serum cholesterol in vegetarians: The effect of dietary assessment on the correlation coefficient American Journal of Epidemiology. 128: 1054-1074. PMID 3189281 DOI: 10.1093/Oxfordjournals.Aje.A115049 |
0.42 |
|
| 1988 |
Figge HL, Figge J, Souney PF, Mutnick AH, Sacks F. Nicotinic acid: a review of its clinical use in the treatment of lipid disorders. Pharmacotherapy. 8: 287-294. PMID 3075276 DOI: 10.1002/J.1875-9114.1988.Tb04085.X |
0.332 |
|
| 1987 |
Sacks FM, Breslow JL. Very low density lipoproteins stimulate cholesteryl ester formation in U937 macrophages. Heterogeneity and biologic variation among normal humans. Arteriosclerosis, Thrombosis, and Vascular Biology. 7: 35-46. PMID 3813975 DOI: 10.1161/01.Atv.7.1.35 |
0.321 |
|
| 1987 |
Sacks FM, Stampfer MJ, Munoz A, McManus K, Canessa M, Kass EH. Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. Journal of the American College of Nutrition. 6: 179-85. PMID 3584738 DOI: 10.1080/07315724.1987.10720179 |
0.308 |
|
| 1987 |
Sacks FM, Rouse IL, Stampfer MJ, Bishop LM, Lenherr CF, Walther RJ. Effect of dietary fats and carbohydrate on blood pressure of mildly hypertensive patients. Hypertension. 10: 452-460. PMID 3308702 DOI: 10.1161/01.Hyp.10.4.452 |
0.387 |
|
| 1987 |
Dzau VJ, Sacks FM. Regulation of lipoprotein metabolism by adrenergic mechanisms. Journal of Cardiovascular Pharmacology. 10. DOI: 10.1097/00005344-198700109-00002 |
0.34 |
|
| 1986 |
Sacks FM, Handysides GH, Marais GE, Rosner B, Kass EH. Effects of a low-fat diet on plasma lipoprotein levels. Archives of Internal Medicine. 146: 1573-7. PMID 3729638 DOI: 10.1001/Archinte.1986.00360200143023 |
0.445 |
|
| 1986 |
Sacks FM, Dzau VJ. Adrenergic effects on plasma lipoprotein metabolism: Speculation on mechanisms of action The American Journal of Medicine. 80: 71-81. PMID 3080883 DOI: 10.1016/0002-9343(86)90163-4 |
0.377 |
|
| 1986 |
Sacks FM, Ornish D, Kass EH, McLanahan S. In Reply Jama: the Journal of the American Medical Association. 255: 1136-1137. DOI: 10.1001/Jama.1986.03370090058013 |
0.329 |
|
| 1985 |
Sacks FM, Ornish D, Rosner B, McLanahan S, Castelli WP, Kass EH. Plasma lipoprotein levels in vegetarians. The effect of ingestion of fats from dairy products. Jama. 254: 1337-41. PMID 4021011 DOI: 10.1001/Jama.1985.03360100087019 |
0.415 |
|
| 1984 |
Sacks FM, Wood PG, Kass EH. Stability of blood pressure in vegetarians receiving dietary protein supplements. Hypertension. 6: 199-201. PMID 6724661 DOI: 10.1161/01.Hyp.6.2.199 |
0.325 |
|
| 1984 |
Sacks FM, Marais GE, Handysides G, Salazar J, Miller L, Foster JM, Rosner B, Kass EH. Lack of an effect of dietary saturated fat and cholesterol on blood pressure in normotensives. Hypertension. 6: 193-8. PMID 6724660 DOI: 10.1161/01.Hyp.6.2.193 |
0.431 |
|
| 1983 |
Sacks FM. Effects of foods consumed on plasma cholesterol levels. The American Journal of Clinical Nutrition. 37: 883-884. DOI: 10.1093/Ajcn/37.5.883A |
0.332 |
|
| 1981 |
Sacks FM, Donner A, Castelli WP, Gronemeyer J, Pletka P, Margolius HS, Landsberg L, Kass EH. Effect of ingestion of meat on plasma cholesterol of vegetarians. Jama. 246: 640-4. PMID 7019459 DOI: 10.1001/Jama.1981.03320060042020 |
0.417 |
|
| 1975 |
Sacks FM, Castelli WP, Donner A, Kass EH. Plasma lipids and lipoproteins in vegetarians and controls. The New England Journal of Medicine. 292: 1148-51. PMID 164628 DOI: 10.1056/Nejm197505292922203 |
0.426 |
|
| Show low-probability matches. |